{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T19:11:35Z","timestamp":1788462695269,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jchf.2025.02.024","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T12:49:46Z","timestamp":1749559786000},"page":"102478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Transferrin Saturation Is a Better Predictor Than Ferritin of Metabolic and Hemodynamic Exercise Responses in HFpEF"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6692-6880","authenticated-orcid":false,"given":"Sujin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas E.","family":"Houstis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana C.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Slocum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Ostrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Birchenough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Tattersfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haakon","family":"Sigurslid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugene","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Landsteiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer N.","family":"Rouvina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jchf.2025.02.024_bib1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s11886-014-0501-8","article-title":"Heart failure with preserved ejection fraction: current understandings and challenges","volume":"16","author":"Andersen","year":"2014","journal-title":"Curr Cardiol Rep"},{"issue":"5","key":"10.1016\/j.jchf.2025.02.024_bib2","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/CIRCHEARTFAILURE.114.001583","article-title":"Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial","volume":"7","author":"Shah","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"23","key":"10.1016\/j.jchf.2025.02.024_bib3","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1161\/CIRCULATIONAHA.110.011031","article-title":"Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction","volume":"124","author":"Zile","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jchf.2025.02.024_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1253\/circj.CJ-13-1103","article-title":"Mechanisms of exercise intolerance in heart failure with preserved ejection fraction","volume":"78","author":"Borlaug","year":"2014","journal-title":"Circ J"},{"issue":"3","key":"10.1016\/j.jchf.2025.02.024_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jchf.2025.02.024_bib6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/CIRCULATIONAHA.117.029058","article-title":"Exercise intolerance in heart failure with preserved ejection fraction: diagnosing and ranking its causes using personalized O2 pathway analysis","volume":"137","author":"Houstis","year":"2018","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.jchf.2025.02.024_bib7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cardfail.2011.08.003","article-title":"Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure","volume":"17","author":"Jankowska","year":"2011","journal-title":"J Card Fail"},{"issue":"6","key":"10.1016\/j.jchf.2025.02.024_bib8","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1002\/ehf2.13617","article-title":"Impact of change in iron status over time on clinical outcomes in heart failure according to ejection fraction phenotype","volume":"8","author":"Fitzsimons","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"19","key":"10.1016\/j.jchf.2025.02.024_bib9","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1001\/jama.2017.5427","article-title":"Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial","volume":"317","author":"Lewis","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jchf.2025.02.024_bib10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00392-018-1344-x","article-title":"Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life","volume":"108","author":"Bekfani","year":"2019","journal-title":"Clin Res Cardiol"},{"issue":"6","key":"10.1016\/j.jchf.2025.02.024_bib11","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.3390\/ijms24065645","article-title":"Markers of iron metabolism and outcomes in patients with heart failure: a systematic review","volume":"24","author":"Dhaliwal","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.jchf.2025.02.024_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/00015385.2017.1351239","article-title":"Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction","volume":"73","author":"Martens","year":"2018","journal-title":"Acta Cardiol"},{"issue":"1","key":"10.1016\/j.jchf.2025.02.024_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001012","article-title":"Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"6","author":"Beale","year":"2019","journal-title":"Open Heart"},{"issue":"3","key":"10.1016\/j.jchf.2025.02.024_bib14","first-page":"47","article-title":"Hepcidin\u2014the iron regulatory hormone","volume":"26","author":"Rossi","year":"2005","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.jchf.2025.02.024_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104664","article-title":"The role of hepcidin and iron homeostasis in atherosclerosis","volume":"153","author":"Wunderer","year":"2020","journal-title":"Pharmacol Res"},{"issue":"12","key":"10.1016\/j.jchf.2025.02.024_bib16","doi-asserted-by":"crossref","first-page":"E482","DOI":"10.1002\/ajh.24561","article-title":"Iron refractory iron deficiency anemia: a heterogeneous disease that is not always iron refractory","volume":"91","author":"Donker","year":"2016","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.jchf.2025.02.024_bib17","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1097\/MAT.0000000000001811","article-title":"Persistent iron deficiency and dysregulated hepcidin levels after durable left ventricular assist device therapy","volume":"69","author":"Ton","year":"2023","journal-title":"ASAIO J"},{"issue":"16","key":"10.1016\/j.jchf.2025.02.024_bib18","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jchf.2025.02.024_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/CIRCULATIONAHA.118.039136","article-title":"Differential clinical profiles, exercise responses, and outcomes associated with existing HFpEF definitions","volume":"140","author":"Ho","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.02.024_bib20","series-title":"Principles of Exercise Testing and Interpretation","year":"2005"},{"issue":"5","key":"10.1016\/j.jchf.2025.02.024_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004750","article-title":"Pulmonary capillary wedge pressure patterns during exercise predict exercise capacity and incident heart failure","volume":"11","author":"Eisman","year":"2018","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1016\/j.jchf.2025.02.024_bib22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/CIRCHEARTFAILURE.111.965186","article-title":"Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training","volume":"5","author":"Swank","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.jchf.2025.02.024_bib23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jacc.2011.02.055","article-title":"Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction","volume":"58","author":"Haykowsky","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jchf.2025.02.024_bib24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10741-018-9714-z","article-title":"Therapy for heart failure with preserved ejection fraction: current status, unique challenges, and future directions","volume":"23","author":"Upadhya","year":"2018","journal-title":"Heart Fail Rev"},{"issue":"14","key":"10.1016\/j.jchf.2025.02.024_bib25","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.2009.454","article-title":"Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial","volume":"301","author":"O'Connor","year":"2009","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.jchf.2025.02.024_bib26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jchf.2016.03.022","article-title":"Cardiopulmonary exercise testing in heart failure","volume":"4","author":"Malhotra","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"2","key":"10.1016\/j.jchf.2025.02.024_bib27","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCHEARTFAILURE.114.001825","article-title":"Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction","volume":"8","author":"Dhakal","year":"2015","journal-title":"Circ Heart Fail"},{"issue":"7","key":"10.1016\/j.jchf.2025.02.024_bib28","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cardfail.2023.03.025","article-title":"Iron deficiency in heart failure: a scientific statement from the Heart Failure Society of America","volume":"29","author":"Beavers","year":"2023","journal-title":"J Card Fail"},{"issue":"5","key":"10.1016\/j.jchf.2025.02.024_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.000345","article-title":"Oral iron therapy for heart failure with reduced ejection fraction: design and rationale for oral iron repletion effects on oxygen uptake in heart failure","volume":"9","author":"Lewis","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2025.02.024_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102164","article-title":"Mitochondrial iron-sulfur clusters: Structure, function, and an emerging role in vascular biology","volume":"47","author":"Read","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.jchf.2025.02.024_bib31","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.freeradbiomed.2018.08.010","article-title":"Mechanisms of cardiac iron homeostasis and their importance to heart function","volume":"133","author":"Lakhal-Littleton","year":"2019","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.jchf.2025.02.024_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/17474086.2016.1268047","article-title":"Mitochondria and iron: current questions","volume":"10","author":"Paul","year":"2017","journal-title":"Expert Rev Hematol"},{"issue":"12","key":"10.1016\/j.jchf.2025.02.024_bib33","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","article-title":"Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival","volume":"58","author":"Okonko","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.jchf.2025.02.024_bib34","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.jacc.2006.08.034","article-title":"Etiology of anemia in patients with advanced heart failure","volume":"48","author":"Nanas","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jchf.2025.02.024_bib35","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20150014","article-title":"Hepcidin: regulation of the master iron regulator","volume":"35","author":"Rishi","year":"2015","journal-title":"Biosci Rep"},{"issue":"8","key":"10.1016\/j.jchf.2025.02.024_bib36","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.cardfail.2021.12.018","article-title":"Relationship between soluble transferrin receptor and clinical outcomes in patients with heart failure according to ejection fraction phenotype: the New Zealand PEOPLE study","volume":"28","author":"Fitzsimons","year":"2022","journal-title":"J Card Fail"},{"issue":"4","key":"10.1016\/j.jchf.2025.02.024_bib37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jacc.2021.11.039","article-title":"Criteria for iron deficiency in patients with heart failure","volume":"79","author":"Masini","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jchf.2025.02.024_bib38","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.bbagen.2010.03.011","article-title":"Serum ferritin: past, present and future","volume":"1800","author":"Wang","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.jchf.2025.02.024_bib39","article-title":"Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients","volume":"11","author":"Grote","year":"2018","journal-title":"Circ Heart Fail"},{"issue":"10266","key":"10.1016\/j.jchf.2025.02.024_bib40","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.jchf.2025.02.024_bib41","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jchf.2025.02.024_bib42","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.jchf.2025.02.024_bib43","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","article-title":"Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency","volume":"136","author":"van Veldhuisen","year":"2017","journal-title":"Circulation"},{"issue":"10369","key":"10.1016\/j.jchf.2025.02.024_bib44","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jchf.2025.02.024_bib45","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa2304968","article-title":"Ferric carboxymaltose in heart failure with iron deficiency","volume":"389","author":"Mentz","year":"2023","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.jchf.2025.02.024_bib46","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/eurheartj\/ehae086","article-title":"Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial","volume":"45","author":"Cleland","year":"2024","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.jchf.2025.02.024_bib47","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.jchf.2025.02.024_bib48","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/CIRCULATIONAHA.122.060511","article-title":"Iron deficiency in heart failure and effect of dapagliflozin: findings from DAPA-HF","volume":"146","author":"Docherty","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jchf.2025.02.024_bib49","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jchf.2022.10.004","article-title":"Potential interactions when prescribing SGLT2 inhibitors and intravenous iron in combination in heart failure","volume":"11","author":"Packer","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"4","key":"10.1016\/j.jchf.2025.02.024_bib50","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa057","article-title":"Dapagliflozin suppresses hepcidin and increases erythropoiesis","volume":"105","author":"Ghanim","year":"2020","journal-title":"J Clin Endocrinol Metab"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177925003634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177925003634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:25:04Z","timestamp":1785554704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177925003634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2213177925003634"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2025.02.024","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transferrin Saturation Is a Better Predictor Than Ferritin of Metabolic and Hemodynamic Exercise Responses in HFpEF","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2025.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}],"article-number":"102478"}}